- Home
- FUSB vs COEP Comparison
FUSB vs COEP Comparison
Compare FUSB & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- COEP
- Stock Information
- Founded
- FUSB 1952
- COEP 2017
- Country
- FUSB United States
- COEP United States
- Employees
- FUSB N/A
- COEP N/A
- Industry
- FUSB Major Banks
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FUSB Finance
- COEP Health Care
- Exchange
- FUSB Nasdaq
- COEP Nasdaq
- Market Cap
- FUSB 69.3M
- COEP 62.4M
- IPO Year
- FUSB N/A
- COEP N/A
- Fundamental
- Price
- FUSB $12.00
- COEP $13.01
- Analyst Decision
- FUSB
- COEP
- Analyst Count
- FUSB 0
- COEP 0
- Target Price
- FUSB N/A
- COEP N/A
- AVG Volume (30 Days)
- FUSB 3.9K
- COEP 44.5K
- Earning Date
- FUSB 10-23-2025
- COEP 11-12-2025
- Dividend Yield
- FUSB 2.33%
- COEP N/A
- EPS Growth
- FUSB N/A
- COEP N/A
- EPS
- FUSB 0.97
- COEP N/A
- Revenue
- FUSB $36,046,000.00
- COEP $263,555.00
- Revenue This Year
- FUSB N/A
- COEP N/A
- Revenue Next Year
- FUSB N/A
- COEP N/A
- P/E Ratio
- FUSB $12.08
- COEP N/A
- Revenue Growth
- FUSB N/A
- COEP N/A
- 52 Week Low
- FUSB $10.30
- COEP $2.31
- 52 Week High
- FUSB $14.30
- COEP $14.70
- Technical
- Relative Strength Index (RSI)
- FUSB 50.32
- COEP 55.25
- Support Level
- FUSB $11.00
- COEP $12.09
- Resistance Level
- FUSB $12.22
- COEP $13.53
- Average True Range (ATR)
- FUSB 0.57
- COEP 0.74
- MACD
- FUSB 0.07
- COEP -0.14
- Stochastic Oscillator
- FUSB 61.98
- COEP 53.57
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services, and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals, and other individuals.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.